Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines*****2GSeC7z1Ul
— National File (@NationalFile) September 1, 2021
Success against #COVID19 will likely require both vaccines & treatments. We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate—specifically designed to combat SARS-CoV-2—in non-hospitalized, low-risk adults: *****su5VtfbWPX
— AlbertBourla (@AlbertBourla) September 1, 2021